par Salcedo, Margarita;Bercovici, Nadège;Taylor, Rachel;Vereecken, Pierre ;Massicard, Séverine;Duriau, Dominique;Vernel-Pauillac, Frédérique;Boyer, Aurélie;Baron-Bodo, Véronique;Mallard, Eric;Bartholeyns, Jacques;Goxe, Béatrice;Latour, Nathalie;Leroy, Sophie;Prigent, Didier;Martiat, Philippe ;Sales, Francois;Laporte, Marianne;Bruyns, Catherine ;Romet-Lemonne, Jean-Loup;Abastado, Jean-Pierre;Lehmann, Frédéric ;Velu, Thierry
Référence Cancer immunology and immunotherapy, 55, 7, page (819-829)
Publication Publié, 2006-07
Référence Cancer immunology and immunotherapy, 55, 7, page (819-829)
Publication Publié, 2006-07
Article révisé par les pairs
Titre: |
|
Auteur: | Salcedo, Margarita; Bercovici, Nadège; Taylor, Rachel; Vereecken, Pierre; Massicard, Séverine; Duriau, Dominique; Vernel-Pauillac, Frédérique; Boyer, Aurélie; Baron-Bodo, Véronique; Mallard, Eric; Bartholeyns, Jacques; Goxe, Béatrice; Latour, Nathalie; Leroy, Sophie; Prigent, Didier; Martiat, Philippe; Sales, Francois; Laporte, Marianne; Bruyns, Catherine; Romet-Lemonne, Jean-Loup; Abastado, Jean-Pierre; Lehmann, Frédéric; Velu, Thierry |
Informations sur la publication: | Cancer immunology and immunotherapy, 55, 7, page (819-829) |
Statut de publication: | Publié, 2006-07 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Allogeneic melanoma lysate |
Dendritic cells Immunotherapy | |
Human clinical trial | |
T-cell responses | |
MeSH keywords: | Adult |
Aged | |
Antigens, Neoplasm -- administration & dosage | |
Antigens, Neoplasm -- therapeutic use | |
Cancer Vaccines -- adverse effects | |
Cancer Vaccines -- therapeutic use | |
Cell Line, Tumor -- chemistry | |
Cell Line, Tumor -- immunology | |
Cells, Cultured -- drug effects | |
Cells, Cultured -- immunology | |
Cells, Cultured -- transplantation | |
Culture Media, Serum-Free | |
Dendritic Cells -- drug effects | |
Dendritic Cells -- immunology | |
Dendritic Cells -- transplantation | |
Female | |
Granulocyte-Macrophage Colony-Stimulating Factor -- pharmacology | |
HLA-A2 Antigen -- immunology | |
Hepatitis B Surface Antigens -- administration & dosage | |
Humans | |
Injections | |
Injections, Intradermal | |
Injections, Subcutaneous | |
Interleukin-13 -- pharmacology | |
Isoantigens -- administration & dosage | |
Isoantigens -- therapeutic use | |
Liver Neoplasms -- immunology | |
Liver Neoplasms -- secondary | |
Liver Neoplasms -- therapy | |
Lung Neoplasms -- immunology | |
Lung Neoplasms -- secondary | |
Lung Neoplasms -- therapy | |
Lymph Nodes | |
Lymphatic Metastasis | |
Male | |
Melanoma -- immunology | |
Melanoma -- secondary | |
Melanoma -- therapy | |
Middle Aged | |
Skin Neoplasms -- immunology | |
Skin Neoplasms -- therapy | |
Tetanus Toxoid -- administration & dosage | |
Tissue Extracts -- administration & dosage | |
Tissue Extracts -- immunology | |
Tissue Extracts -- therapeutic use | |
Treatment Outcome | |
Vaccination -- adverse effects | |
Note générale: | Clinical Trial, Phase I |
Clinical Trial, Phase II | |
Journal Article | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0340-7004 |
info:doi/10.1007/s00262-005-0078-6 | |
info:scp/33645297917 | |
info:pmid/16187085 |